Mitogen-activated protein kinase-mediated licensing of interferon regulatory factor 3/7 reinforces the cell response to virus

Journal of Biological Chemistry

Volumn 289, Issue 1, 2014, Pages 299-311

  Schmid, Sonja ^a   Sachs, David ^a   Ten Oever, Benjamin R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; GLYCOPROTEINS; VIRUSES;

CELLULAR RESPONSE; FEEDFORWARD LOOPS; GENETIC MATERIALS; IMMINENT THREATS; INTERFERON REGULATORY FACTORS; MITOGEN-ACTIVATED PROTEINS; TRANSCRIPTIONAL ACTIVITY; TRANSCRIPTOMES;

ANTIBIOTICS;

BETA INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; TRANSCRIPTOME; IRF3 PROTEIN, HUMAN; IRF3 PROTEIN, MOUSE; IRF7 PROTEIN, HUMAN; IRF7 PROTEIN, MOUSE; MAP3K8 PROTEIN, HUMAN; MAP3K8 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; ONCOPROTEIN; PROTEIN S 100;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE EXPRESSION; INFECTION RESISTANCE; MAP3K8 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SP100 GENE; SP110 GENE; SP140 GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; CELL LINE; ENZYME INDUCTION; GENETICS; HUMAN; METABOLISM; MOUSE; PROTEIN MULTIMERIZATION; RHABDOVIRUS INFECTION; VESICULOVIRUS;

ANIMALS; CELL LINE; ENZYME INDUCTION; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICE; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS; RHABDOVIRIDAE INFECTIONS; S100 PROTEINS; VESICULOVIRUS;

EID: 84891698462     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.519934     Document Type: Article

References (91)

1. Akira, S., Uematsu, S., and Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801 (Pubitemid 43261452)
2. Alexopoulou, L., Holt, A. C., Medzhitov, R., and Flavell, R. A. (2001) Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732-738 (Pubitemid 33009951)
3. Meylan, E., Tschopp, J., and Karin, M. (2006) Intracellular pattern recognition receptors in the host response. Nature 442, 39-44 (Pubitemid 44064203)
4. Levy, D. E., Marié, I. J., and Durbin, J. E. (2011) Induction and function of type I and III interferon in response to viral infection. Curr. Opin. Virol. 1, 476-486
5. Maniatis, T., Falvo, J. V., Kim, T. H., Kim, T. K., Lin, C. H., Parekh, B. S., and Wathelet, M. G. (1998) Structure and function of the interferon-β enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63, 609-620
6. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421 (Pubitemid 24217131)
7. Li, J., Ding, S. C., Cho, H., Chung, B. C., Gale, M., Jr., Chanda, S. K., and Diamond, M. S. (2013) A short hairpin RNA screen of interferon-stimulated genes identifies a novel negative regulator of the cellular antiviral response. MBio 4, e00385-e00313
8. Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., and Rice, C. M. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485
9. Sadler, A. J., and Williams, B. R. (2008) Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559-568 (Pubitemid 351913674)
10. Ireton, R. C., and Gale, M., Jr. (2011) RIG-I like receptors in antiviral immunity and therapeutic applications. Viruses 3, 906-919
11. Yoshimura, A., Naka, T., and Kubo, M. (2007) SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465 (Pubitemid 46834848)
12. Mamane, Y., Heylbroeck, C., Génin, P., Algarté, M., Servant, M. J., Le Page, C., De Luca, C., Kwon, H., Lin, R., and Hiscott, J. (1999) Interferon regulatory factors. The next generation. Gene 237, 1-14 (Pubitemid 29406192)
13. Harada, H., Takahashi, E., Itoh, S., Harada, K., Hori, T. A., and Taniguchi, T. (1994) Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes. Implications for a gene network in the interferon system. Mol. Cell Biol. 14, 1500-1509
14. Feng, D., Sangster-Guity, N., Stone, R., Korczeniewska, J., Mancl, M. E., Fitzgerald-Bocarsly, P., and Barnes, B. J. (2010) Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression. J. Immunol. 185, 6003-6012
15. Lazear, H. M., Lancaster, A., Wilkins, C., Suthar, M. S., Huang, A., Vick, S. C., Clepper, L., Thackray, L., Brassil, M. M., Virgin, H. W., Nikolich-Zugich, J., Moses, A. V., Gale, M., Jr., Früh, K., and Diamond, M. S. (2013) IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 9, e1003118
16. Veals, S. A., Schindler, C., Leonard, D., Fu, X. Y., Aebersold, R., Darnell, J. E., Jr., and Levy, D. E. (1992) Subunit of an α-interferon- responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol. Cell Biol. 12, 3315-3324
17. Génin, P., Lin, R., Hiscott, J., and Civas, A. (2009) Differential regulation of human interferonAgene expression by interferon regulatory factors 3 and 7. Mol. Cell Biol. 29, 3435-3450
18. Barnes, B. J., Richards, J., Mancl, M., Hanash, S., Beretta, L., and Pitha, P. M. (2004) Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J. Biol. Chem. 279, 45194-45207 (Pubitemid 39430935)
19. Chattopadhyay, S., Fensterl, V., Zhang, Y., Veleeparambil, M., Yamashita, M., and Sen, G. C. (2013) Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus. J. Virol. 87, 16-24
20. Schmid, S., Mordstein, M., Kochs, G., García-Sastre, A., and Tenoever, B. R. (2010) Transcription factor redundancy ensures induction of the antiviral state. J. Biol. Chem. 285, 42013-42022
21. Panne, D., Maniatis, T., and Harrison, S. C. (2007) An atomic model of the interferon-β enhanceosome. Cell 129, 1111-1123
22. Escalante, C. R., Nistal-Villán, E., Shen, L., García-Sastre, A., and Aggarwal, A. K. (2007) Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-β enhancer. Mol. Cell 26, 703-716 (Pubitemid 46856241)
23. Grandvaux, N., Servant, M. J., Ten Oever, B., Sen, G. C., Balachandran, S., Barber, G. N., Lin, R., and Hiscott, J. (2002) Transcriptional profiling of interferon regulatory factor 3 target genes. Direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76, 5532-5539 (Pubitemid 34517903)
24. Tanaka, N., Kawakami, T., and Taniguchi, T. (1993) Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell Biol. 13, 4531-4538 (Pubitemid 23220360)
25. Fujii, Y., Shimizu, T., Kusumoto, M., Kyogoku, Y., Taniguchi, T., and Hakoshima, T. (1999) Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. EMBO J. 18, 5028-5041 (Pubitemid 29443805)
26. Veals, S. A., Santa Maria, T., and Levy, D. E. (1993) Two domains of ISGF3γ that mediate protein-DNA and protein-protein interactions during transcription factor assembly contribute to DNA-binding specificity. Mol. Cell Biol. 13, 196-206 (Pubitemid 23006897)
27. Sato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S., Tanaka, N., and Taniguchi, T. (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13, 539-548
28. Marié, I., Durbin, J. E., and Levy, D. E. (1998) Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J. 17, 6660-6669 (Pubitemid 28521799)
29. Taniguchi, T., Ogasawara, K., Takaoka, A., and Tanaka, N. (2001) IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655 (Pubitemid 32368048)
30. Morin, P., Bragança, J., Bandu, M. T., Lin, R., Hiscott, J., Doly, J., and Civas, A. (2002) Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription. J. Mol. Biol. 316, 1009-1022 (Pubitemid 34729220)
31. Lin, R., Génin, P., Mamane, Y., and Hiscott, J. (2000) Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of α/β interferon genes by interferon regulatory factors 3 and 7. Mol. Cell Biol. 20, 6342-6353 (Pubitemid 30650221)
32. Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., and Taniguchi, T. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434, 772-777 (Pubitemid 44739521)
33. Farlik, M., Rapp, B., Marie, I., Levy, D. E., Jamieson, A. M., and Decker, T. (2012) Contribution of a TANK-binding kinase 1-interferon (IFN) regulatory factor 7 pathway to IFN-γ-induced gene expression. Mol. Cell Biol. 32, 1032-1043
34. Vougioukalaki, M., Kanellis, D. C., Gkouskou, K., and Eliopoulos, A. G. (2011) Tpl2 kinase signal transduction in inflammation and cancer. Cancer Lett. 304, 80-89
35. Beinke, S., Deka, J., Lang, V., Belich, M. P., Walker, P. A., Howell, S., Smerdon, S. J., Gamblin, S. J., and Ley, S. C. (2003) NF-κB1 p105 negatively regulates TPL-2 MEK kinase activity. Mol. Cell Biol. 23, 4739-4752 (Pubitemid 36793322)
36. Waterfield, M. R., Zhang, M., Norman, L. P., and Sun, S. C. (2003) NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Mol. Cell 11, 685-694 (Pubitemid 36385122)
37. Das, S., Cho, J., Lambertz, I., Kelliher, M. A., Eliopoulos, A. G., Du, K., and Tsichlis, P. N. (2005) Tpl2/cot signals activate ERK, JNK, and NF-κB in a cell-type and stimulus-specific manner. J. Biol. Chem. 280, 23748-23757 (Pubitemid 40884858)
38. Eliopoulos, A. G., Wang, C. C., Dumitru, C. D., and Tsichlis, P. N. (2003) Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. EMBO J. 22, 3855-3864 (Pubitemid 36975712)
39. Dumitru, C. D., Ceci, J. D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J. H., Patriotis, C., Jenkins, N. A., Copeland, N. G., Kollias, G., and Tsichlis, P. N. (2000) TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103, 1071-1083 (Pubitemid 32040907)
40. Eliopoulos, A. G., Dumitru, C. D., Wang, C. C., Cho, J., and Tsichlis, P. N. (2002) Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 21, 4831-4840
41. Chiariello, M., Marinissen, M. J., and Gutkind, J. S. (2000) Multiple mitogenactivated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation. Mol. Cell Biol. 20, 1747-1758 (Pubitemid 30100193)
42. Salmeron, A., Ahmad, T. B., Carlile, G. W., Pappin, D., Narsimhan, R. P., and Ley, S. C. (1996) Activation of MEK-1 and SEK-1 by Tpl-2 protooncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15, 817-826
43. Tsatsanis, C., Patriotis, C., Bear, S. E., and Tsichlis, P. N. (1998) The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines. Proc. Natl. Acad. Sci. U. S. A. 95, 3827-3832 (Pubitemid 28173214)
44. Xiao, N., Eidenschenk, C., Krebs, P., Brandl, K., Blasius, A. L., Xia, Y., Khovananth, K., Smart, N. G., and Beutler, B. (2009) The Tpl2 mutation Sluggish impairs type I IFN production and increases susceptibility to group B streptococcal disease. J. Immunol. 183, 7975-7983
45. Mielke, L. A., Elkins, K. L., Wei, L., Starr, R., Tsichlis, P. N., O'Shea, J. J., and Watford, W. T. (2009) Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1β production. J. Immunol. 183, 7984-7993
46. Kaiser, F., Cook, D., Papoutsopoulou, S., Rajsbaum, R., Wu, X., Yang, H. T., Grant, S., Ricciardi-Castagnoli, P., Tsichlis, P. N., Ley, S. C., and O'Garra, A. (2009) TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells. J. Exp. Med. 206, 1863-1871
47. Yang, H. T., Wang, Y., Zhao, X., Demissie, E., Papoutsopoulou, S., Mambole, A., O'Garra, A., Tomczak, M. F., Erdman, S. E., Fox, J. G., Ley, S. C., and Horwitz, B. H. (2011) NF-κB1 inhibits TLR-induced IFN-β production in macrophages through TPL-2-dependent ERK activation. J. Immunol. 186, 1989-1996
48. Watford, W. T., Hissong, B. D., Durant, L. R., Yamane, H., Muul, L. M., Kanno, Y., Tato, C. M., Ramos, H. L., Berger, A. E., Mielke, L., Pesu, M., Solomon, B., Frucht, D. M., Paul, W. E., Sher, A., Jankovic, D., Tsichlis, P. N., and O'Shea, J. J. (2008) Tpl2 kinase regulates T cell interferon-γ production and host resistance to Toxoplasma gondii. J. Exp. Med. 205, 2803-2812
49. Stojdl, D. F., Lichty, B. D., Ten Oever, B. R., Paterson, J. M., Power, A. T., Knowles, S., Marius, R., Reynard, J., Poliquin, L., Atkins, H., Brown, E. G., Durbin, R. K., Durbin, J. E., Hiscott, J., and Bell, J. C. (2003) VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4, 263-275 (Pubitemid 37329791)
50. Donelan, N. R., Basler, C. F., and García-Sastre, A. (2003) A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of β interferon and is attenuated in mice. J. Virol. 77, 13257-13266 (Pubitemid 37494321)
51. Sharma, S., Ten Oever, B. R., Grandvaux, N., Zhou, G. P., Lin, R., and Hiscott, J. (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151 (Pubitemid 36583100)
52. Mibayashi, M., Martínez-Sobrido, L., Loo, Y. M., Cárdenas, W. B., Gale, M., Jr., and García-Sastre, A. (2007) Inhibition of retinoic acid-inducible gene I-mediated induction of β interferon by the NS1 protein of influenza A virus. J. Virol. 81, 514-524 (Pubitemid 46067878)
53. Niwa, H., Yamamura, K., and Miyazaki, J. (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-199
54. Newhart, A., Negorev, D. G., Rafalska-Metcalf, I. U., Yang, T., Maul, G. G., and Janicki, S. M. (2013) Sp100A promotes chromatin decondensation at a cytomegalovirus-promoter-regulated transcription site. Mol. Biol. Cell 24, 1454-1468
55. Ten Oever, B. R., Ng, S. L., Chua, M. A., McWhirter, S. M., García-Sastre, A., and Maniatis, T. (2007) Multiple functions of the IKK-related kinase IKKε in interferon-mediated antiviral immunity. Science 315, 1274-1278 (Pubitemid 46364264)
56. Perez, J. T., Varble, A., Sachidanandam, R., Zlatev, I., Manoharan, M., García-Sastre, A., and Ten Oever, B. R. (2010) Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc. Natl. Acad. Sci. U. S. A. 107, 11525-11530
57. Varble, A., Benitez, A. A., Schmid, S., Sachs, D., Shim, J. V., Rodriguez-Barrueco, R., Panis, M., Crumiller, M., Silva, J. M., Sachidanandam, R., and Tenoever, B. R. (2013) An in vivo RNAi screening approach to identify host determinants of virus replication. Cell Host Microbe 14, 346-356
58. Levy, D. E., Kessler, D. S., Pine, R., Reich, N., and Darnell, J. E., Jr. (1988) Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev. 2, 383-393
59. Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S. M., and Maniatis, T. (2003) IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496 (Pubitemid 36592443)
60. Qin, B. Y., Liu, C., Lam, S. S., Srinath, H., Delston, R., Correia, J. J., Derynck, R., and Lin, K. (2003) Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat. Struct. Biol. 10, 913-921 (Pubitemid 37386100)
61. Takahasi, K., Suzuki, N. N., Horiuchi, M., Mori, M., Suhara, W., Okabe, Y., Fukuhara, Y., Terasawa, H., Akira, S., Fujita, T., and Inagaki, F. (2003) X-ray crystal structure of IRF-3 and its functional implications. Nat. Struct. Biol. 10, 922-927 (Pubitemid 37386101)
62. Yang, H., Lin, C. H., Ma, G., Orr, M., Baffi, M. O., and Wathelet, M. G. (2002) Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions. Eur. J. Biochem. 269, 6142-6151 (Pubitemid 35461827)
63. Lin, R., Mamane, Y., and Hiscott, J. (2000) Multiple regulatory domains control IRF-7 activity in response to virus infection. J. Biol. Chem. 275, 34320-34327
64. Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M., and Maniatis, T. (1998) Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell 1, 507-518 (Pubitemid 128374687)
65. Rand, U., Rinas, M., Schwerk, J., Nöhren, G., Linnes, M., Kröger, A., Flossdorf, M., Kály-Kullai, K., Hauser, H., Höfer, T., and Köster, M. (2012) Multi-layered stochasticity and paracrine signal propagation shape the type-I interferon response. Mol. Syst. Biol. 8, 584
66. Servant, M. J., Grandvaux, N., Ten Oever, B. R., Duguay, D., Lin, R., and Hiscott, J. (2003) Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J. Biol. Chem. 278, 9441-9447 (Pubitemid 36800435)
67. Wang, J. T., Doong, S. L., Teng, S. C., Lee, C. P., Tsai, C. H., and Chen, M. R. (2009) Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway. J. Virol. 83, 1856-1869
68. Au, W. C., Yeow, W. S., and Pitha, P. M. (2001) Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3. Virology 280, 273-282 (Pubitemid 34165357)
69. Chen, W., Lam, S. S., Srinath, H., Jiang, Z., Correia, J. J., Schiffer, C. A., Fitzgerald, K. A., Lin, K., and Royer, W. E., Jr. (2008) Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat. Struct. Mol. Biol. 15, 1213-1220
70. Borden, K. L. (2008) Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies. Can we fit the pieces together using an RNA regulon? Biochim. Biophys. Acta 1783, 2145-2154
71. Geoffroy, M. C., and Chelbi-Alix, M. K. (2011) Role of promyelocytic leukemia protein in host antiviral defense. J. Interferon Cytokine Res. 31, 145-158
72. Lallemand-Breitenbach, V., and De Thé, H. (2010) PML nuclear bodies. Cold Spring Harb. Perspect. Biol. 2, a000661
73. Grötzinger, T., Jensen, K., and Will, H. (1996) The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-γ activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J. Biol. Chem. 271, 25253-25260 (Pubitemid 26337891)
74. Doody, G. M., Care, M. A., Burgoyne, N. J., Bradford, J. R., Bota, M., Bonifer, C., Westhead, D. R., and Tooze, R. M. (2010) An extended set of PRDM1/BLIMP1 target genes links binding motif type to dynamic repression. Nucleic Acids Res. 38, 5336-5350
75. Wang, J., Shiels, C., Sasieni, P., Wu, P. J., Islam, S. A., Freemont, P. S., and Sheer, D. (2004) Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J. Cell Biol. 164, 515-526 (Pubitemid 38233313)
76. Seth, R. B., Sun, L., Ea, C. K., and Chen, Z. J. (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 122, 669-682 (Pubitemid 41242633)
77. Fensterl, V., and Sen, G. C. (2009) Interferons and viral infections. Biofactors 35, 14-20
78. Thakar, J., Schmid, S., Duke, J. L., Garcia-Sastre, A., and Kleinstein, S. H. (2013) Overcoming NS1-mediated immune antagonism involves both interferondependent and independent mechanisms. J. Interferon Cytokine Res. 33, 700-708
79. Baum, A., Sachidanandam, R., and García-Sastre, A. (2010) Preference of RIG-I for short viral RNA molecules in infected cells revealed by nextgeneration sequencing. Proc. Natl. Acad. Sci. U. S. A. 107, 16303-16308
80. Langlois, R. A., Varble, A., Chua, M. A., García-Sastre, A., and Ten Oever, B. R. (2012) Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proc. Natl. Acad. Sci. U. S. A. 109, 12117-12122
81. Rehwinkel, J., Tan, C. P., Goubau, D., Schulz, O., Pichlmair, A., Bier, K., Robb, N., Vreede, F., Barclay, W., Fodor, E., and Reis E Sousa, C. (2010) RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140, 397-408
82. Moltedo, B., Li, W., Yount, J. S., and Moran, T. M. (2011) Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection. PLoS Pathog. 7, e1002345
83. Kumar, P. P., Bischof, O., Purbey, P. K., Notani, D., Urlaub, H., Dejean, A., and Galande, S. (2007) Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHCclass I locus. Nat. Cell Biol. 9, 45-56 (Pubitemid 46024196)
84. Ulbricht, T., Alzrigat, M., Horch, A., Reuter, N., Von Mikecz, A., Steimle, V., Schmitt, E., Krämer, O. H., Stamminger, T., and Hemmerich, P. (2012) PML promotes MHC class II gene expression by stabilizing the class II transactivator. J. Cell Biol. 199, 49-63
85. Hayakawa, F., and Privalsky, M. L. (2004) Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxidemediated apoptosis. Cancer Cell 5, 389-401 (Pubitemid 38482074)
86. Bonilla, W. V., Pinschewer, D. D., Klenerman, P., Rousson, V., Gaboli, M., Pandolfi, P. P., Zinkernagel, R. M., Salvato, M. S., and Hengartner, H. (2002) Effects of promyelocytic leukemia protein on virus-host balance. J. Virol. 76, 3810-3818 (Pubitemid 34250546)
87. Blondel, D., Kheddache, S., Lahaye, X., Dianoux, L., and Chelbi-Alix, M. K. (2010) Resistance to rabies virus infection conferred by the PMLIV isoform. J. Virol. 84, 10719-10726
88. Iki, S., Yokota, S., Okabayashi, T., Yokosawa, N., Nagata, K., and Fujii, N. (2005) Serum-dependent expression of promyelocytic leukemia protein suppresses propagation of influenza virus. Virology 343, 106-115 (Pubitemid 41572237)
89. Chelbi-Alix, M. K., Quignon, F., Pelicano, L., Koken, M. H., and De Thé, H. (1998) Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72, 1043-1051 (Pubitemid 28116883)
90. Tavalai, N., and Stamminger, T. (2008) New insights into the role of the subnuclear structure ND10 for viral infection. Biochim. Biophys. Acta 1783, 2207-2221
91. Xu, J., Hopkins, K., Sabin, L., Yasunaga, A., Subramanian, H., Lamborn, I., Gordesky-Gold, B., and Cherry, S. (2013) ERK signaling couples nutrient status to antiviral defense in the insect gut. Proc. Natl. Acad. Sci. U. S. A. 110, 15025-15030